Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

KPT-330 Vs Placebo In Pts W/ Advanced Unresectable DDLS

Protocol: OSU-17193

Full Title

A Phase II-III, Multicenter, Randomized, Doubleblind Study Of Selinexor (KPT-330) Versus Placebo In Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)

Sarcoma Soft Tissue Sarcoma